CNTX-6970

DRUG2 trials

Sponsors

Centrexion Therapeutics, Maurizio Fava, MD

Conditions

Chronic PainKnee OsteoarthritisNociceptive Pain

Phase 1

A Placebo-Controlled, Two-Part Study, Oral Dose to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of CNTX-6970 in Healthy Subjects

CompletedNCT03787004

Centrexion TherapeuticsChronic Pain, Nociceptive Pain

Start: 2017-08-14End: 2018-09-26Updated: 2018-12-26

Phase 2

A Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Knee Osteoarthritis Pain.

CompletedNCT05025787

Maurizio Fava, MDKnee Osteoarthritis

Start: 2021-10-25End: 2024-06-11Updated: 2025-11-26